• No se han encontrado resultados

Characterization and risk estimate of cancer in patients with primary Sjögren syndrome

N/A
N/A
Protected

Academic year: 2020

Share "Characterization and risk estimate of cancer in patients with primary Sjögren syndrome"

Copied!
12
0
0

Texto completo

Loading

Figure

Table 1 Baseline SjS-related features and risk of development of solid and hematological cancer
Table 2 summarizes the relationship between organ-by- organ-by-organ baseline ESSDAI activity at diagnosis and the risk of hematological and solid cancer
Table 2 Association between organ-by-organ baseline ESSDAI activity at diagnosis and the risk of development of solid and hematological cancer
Table 3 Association between organ-by-organ baseline ESSDAI activity at diagnosis and the risk of development of the three main subtypes of hematological cancer
+2

Referencias

Documento similar

Evidence that non-lipid cardiovascular risk factors are associated with high prevalence of coronary artery disease in patients with heterozygous familial hypercholesterolemia

1.6 Recombinant production in E.coli and characterization of the proteolytic activity of different constructs of the Catalytic Domain of USP28 and USP25 with

In the NHANES I Epidemiologic Follow-Up Study, recreational physical activity was inversely associated with body mass index, average 10-year weight change, and risk of

8-10 In the case of our patient, he had an isolated sacral metastasis from prostate cancer with no involvement of any other organ, with a very good health condition and high

THM exposure was found to be associated with an increased risk of bladder cancer among men, while among women no association was observed with any of the exposure indices that

A cost-effectiveness analysis was performed comparing once-daily UMEC/VI with once-daily TIO/OLO in symp- tomatic patients with stable COPD at low risk of exacer- bations from

For all these reasons, patients with adrenal insufficiency may be at higher risk of medical complications and eventually at increased mortality risk in the case

The aim of our study was to evaluate the association between excess weight and cancer immunotherapy outcome and toxicity in patients with advanced solid and hematological tumors